Archrock, Inc. current report, 03 August 2011

Business Context and Reporting Period

This Form 8-K is a current report filed by Exterran Holdings, Inc. (noted as Archrock, Inc. in metadata) on August 3, 2011. The filing discloses the pending departure of Ernie L. Danner, the company's President and Chief Executive Officer, effective on or around October 31, 2011.

Key Financial Metrics

The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only specific financial figure disclosed relates to executive compensation:

  • Severance Payment: A lump sum of $1,225,000 to be paid to Mr. Danner.
  • Equity Vesting: Accelerated full vesting of outstanding restricted stock, performance shares, and phantom units with distribution equivalent rights.

Material Changes

The primary material change is the leadership transition and the associated compensation agreement:

  • Executive Departure: Mr. Danner will resign as CEO, President, and Chairman of the Board of Exterran GP LLC, as well as a member of the Exterran Holdings board.
  • Compensation Adjustments: The Compensation Committee approved amendments to award agreements to accelerate vesting of all unvested equity awards upon the date of departure.
  • Restrictive Covenants: Mr. Danner agreed to a two-year non-solicitation of employees and a two-year non-compete restriction regarding the company's business.

Outlook, Risks, and Management Commentary

The filing does not contain forward-looking guidance, general management commentary on business outlook, or specific risk factors beyond the immediate impact of the CEO's departure. The document notes that the board may assign Mr. Danner to another position prior to October 10, 2011, though the primary plan is his departure.

Key Facts for Investor Verification

  • Verify the exact date of Mr. Danner's departure within the window of October 10 to December 31, 2011.
  • Review the attached Separation Agreement (Exhibit 10.1) for detailed terms regarding the $1,225,000 severance and medical benefits.
  • Confirm the valuation of the accelerated equity awards (restricted stock, performance shares, and phantom units) to assess the total cost of the separation.
  • Monitor subsequent filings for the appointment of a successor CEO and any interim leadership arrangements.